Report Detail

Pharma & Healthcare Global Parkinson’s Disease Therapeutics Market Professional Survey Report 2019

  • RnM3733108
  • |
  • 07 September, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. 

The global Parkinson’s Disease Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parkinson’s Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson’s Disease Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson’s Disease Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parkinson’s Disease Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion

Segment by Application
Hospitals
Clinics
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Parkinson’s Disease Therapeutics

      • 1.1 Definition of Parkinson’s Disease Therapeutics
      • 1.2 Parkinson’s Disease Therapeutics Segment by Type
        • 1.2.1 Global Parkinson’s Disease Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Transdermal
        • 1.2.4 Subcutaneous
        • 1.2.5 Intestinal Infusion
      • 1.3 Parkinson’s Disease Therapeutics Segment by Applications
        • 1.3.1 Global Parkinson’s Disease Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Parkinson’s Disease Therapeutics Overall Market
        • 1.4.1 Global Parkinson’s Disease Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Parkinson’s Disease Therapeutics Production (2014-2025)
        • 1.4.3 North America Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Parkinson’s Disease Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Parkinson’s Disease Therapeutics
      • 2.3 Manufacturing Process Analysis of Parkinson’s Disease Therapeutics
      • 2.4 Industry Chain Structure of Parkinson’s Disease Therapeutics

      3 Development and Manufacturing Plants Analysis of Parkinson’s Disease Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Parkinson’s Disease Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Parkinson’s Disease Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Parkinson’s Disease Therapeutics Production and Capacity Analysis
      • 4.2 Parkinson’s Disease Therapeutics Revenue Analysis
      • 4.3 Parkinson’s Disease Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Parkinson’s Disease Therapeutics Regional Market Analysis

      • 5.1 Parkinson’s Disease Therapeutics Production by Regions
        • 5.1.1 Global Parkinson’s Disease Therapeutics Production by Regions
        • 5.1.2 Global Parkinson’s Disease Therapeutics Revenue by Regions
      • 5.2 Parkinson’s Disease Therapeutics Consumption by Regions
      • 5.3 North America Parkinson’s Disease Therapeutics Market Analysis
        • 5.3.1 North America Parkinson’s Disease Therapeutics Production
        • 5.3.2 North America Parkinson’s Disease Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Parkinson’s Disease Therapeutics Import and Export
      • 5.4 Europe Parkinson’s Disease Therapeutics Market Analysis
        • 5.4.1 Europe Parkinson’s Disease Therapeutics Production
        • 5.4.2 Europe Parkinson’s Disease Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Parkinson’s Disease Therapeutics Import and Export
      • 5.5 China Parkinson’s Disease Therapeutics Market Analysis
        • 5.5.1 China Parkinson’s Disease Therapeutics Production
        • 5.5.2 China Parkinson’s Disease Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Parkinson’s Disease Therapeutics Import and Export
      • 5.6 Japan Parkinson’s Disease Therapeutics Market Analysis
        • 5.6.1 Japan Parkinson’s Disease Therapeutics Production
        • 5.6.2 Japan Parkinson’s Disease Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Parkinson’s Disease Therapeutics Import and Export
      • 5.7 Southeast Asia Parkinson’s Disease Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Parkinson’s Disease Therapeutics Production
        • 5.7.2 Southeast Asia Parkinson’s Disease Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Parkinson’s Disease Therapeutics Import and Export
      • 5.8 India Parkinson’s Disease Therapeutics Market Analysis
        • 5.8.1 India Parkinson’s Disease Therapeutics Production
        • 5.8.2 India Parkinson’s Disease Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Parkinson’s Disease Therapeutics Import and Export

      6 Parkinson’s Disease Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Parkinson’s Disease Therapeutics Production by Type
      • 6.2 Global Parkinson’s Disease Therapeutics Revenue by Type
      • 6.3 Parkinson’s Disease Therapeutics Price by Type

      7 Parkinson’s Disease Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Parkinson’s Disease Therapeutics Consumption by Application
      • 7.2 Global Parkinson’s Disease Therapeutics Consumption Market Share by Application (2014-2019)

      8 Parkinson’s Disease Therapeutics Major Manufacturers Analysis

      • 8.1 Abbvie
        • 8.1.1 Abbvie Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.1.2 Abbvie Product Introduction, Application and Specification
        • 8.1.3 Abbvie Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Biogen
        • 8.2.1 Biogen Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.2.2 Biogen Product Introduction, Application and Specification
        • 8.2.3 Biogen Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Boehringer Ingelheim GmbH
        • 8.3.1 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.3.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
        • 8.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 F. Hoffman-La Roche
        • 8.4.1 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.4.2 F. Hoffman-La Roche Product Introduction, Application and Specification
        • 8.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 GlaxoSmithKline
        • 8.5.1 GlaxoSmithKline Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.5.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 H. Lundbeck A/S
        • 8.6.1 H. Lundbeck A/S Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.6.2 H. Lundbeck A/S Product Introduction, Application and Specification
        • 8.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Impax Labs
        • 8.7.1 Impax Labs Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.7.2 Impax Labs Product Introduction, Application and Specification
        • 8.7.3 Impax Labs Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Newron Pharmaceuticals SpA
        • 8.8.1 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.8.2 Newron Pharmaceuticals SpA Product Introduction, Application and Specification
        • 8.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Novartis AG
        • 8.9.1 Novartis AG Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.9.2 Novartis AG Product Introduction, Application and Specification
        • 8.9.3 Novartis AG Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Orion Corporation
        • 8.10.1 Orion Corporation Parkinson’s Disease Therapeutics Production Sites and Area Served
        • 8.10.2 Orion Corporation Product Introduction, Application and Specification
        • 8.10.3 Orion Corporation Parkinson’s Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical Industries Ltd.
      • 8.12 UCB S.A.

      9 Development Trend of Analysis of Parkinson’s Disease Therapeutics Market

      • 9.1 Global Parkinson’s Disease Therapeutics Market Trend Analysis
        • 9.1.1 Global Parkinson’s Disease Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Parkinson’s Disease Therapeutics Regional Market Trend
        • 9.2.1 North America Parkinson’s Disease Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Parkinson’s Disease Therapeutics Forecast 2019-2025
        • 9.2.3 China Parkinson’s Disease Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Parkinson’s Disease Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Parkinson’s Disease Therapeutics Forecast 2019-2025
        • 9.2.6 India Parkinson’s Disease Therapeutics Forecast 2019-2025
      • 9.3 Parkinson’s Disease Therapeutics Market Trend (Product Type)
      • 9.4 Parkinson’s Disease Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Parkinson’s Disease Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Parkinson’s Disease Therapeutics. Industry analysis & Market Report on Parkinson’s Disease Therapeutics is a syndicated market report, published as Global Parkinson’s Disease Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Parkinson’s Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,702.00
        4,053.00
        5,404.00
        3,216.50
        4,824.75
        6,433.00
        532,245.00
        798,367.50
        1,064,490.00
        294,560.00
        441,840.00
        589,120.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report